Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine whether saffron is effective in the pain control after root canal therapy in vital teeth.
Among patients refer to endodontics department of Zahedan Faculty of Dentistry whom with moderate to severe pain in a single canal tooth will be selected and randomly divided in 2 groups of saffron and placebo. After root canal therapy each patient in each group will receive a box of 8 similar capsules. They will use 1 capsule exactly after treatment completion and then each 6 hours up to 48 hours. Patients will record their pain intensity in each time period according to Visual Analog Scale(VAS)and finally mean pain intensity will be compared between 2 groups.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Starch capsule | Placebo Comparator | starch with dose of 100 mg in each capsule every 6 hours up to 48 hours (400 mg/day) |
|
| Saffron capsule | Active Comparator | saffron with dose of 100 mg in each capsule every 6 hours up to 48 hours (400 mg/day) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| starch | Other | 100 mg in each capsule every 6 hours up to 48 hours (400 mg/day) |
| |
| Measure | Description | Time Frame |
|---|---|---|
| change in VAS score | Patients will record their pain intensity in each time period according to Visual Analog Scale (VAS) | Every 6 hours after treatment completion up to 48 hours |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
teeth with periapical lesions
patients with history of:
women in pregnancy or breast feeding period and
use of analgesics or opioids during 4 hours before treatment
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Kaveh Oloomi, DDS, MS | Zahedan University of Medical Sciences | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Zahedan university of medical sciences, Vice-chancellor for research | Zahedan | 98167-43463 | Iran |
Not provided
| ID | Term |
|---|---|
| D010146 | Pain |
| ID | Term |
|---|---|
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D013213 | Starch |
| ID | Term |
|---|---|
| D005936 | Glucans |
| D001704 | Biopolymers |
| D011108 | Polymers |
| D046911 | Macromolecular Substances |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| saffron |
| Other |
100 mg in each capsule every 6 hours up to 48 hours (400 mg/day) |
|
|
| D004040 |
| Dietary Carbohydrates |
| D002241 | Carbohydrates |
| D011134 | Polysaccharides |